Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 23, 2018Oncology Research Featuring Preclinical and Clinical Cancer TherapeuticsOpen Access

lncRNA NORAD Contributes to Colorectal Cancer Progression by Inhibition of miR-202-5p

View Full Paper
Ask AI
Bookmark
Share

Authors

JZJie ZhangZhejiang Chinese Medical UniversityXLXiaoyan LiFuyang City People's HospitalPHPing HuCentral South University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2018) studied this question.

synapsesocial.com/papers/6a943429d5a6dcc35cf649dehttps://doi.org/10.3727/096504018x15190844870055
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 20122014 · 29,264 citations
  2. 2LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-1452017 · 178 citations
  3. 3miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer2017 · 58 citations
  4. 4Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma2017 · 103 citations